Cargando…

KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer

BACKGROUND: KLF16, a member of the Kruppel-like factor (KLF) family, functions in the regulation of dopaminergic transmission, metabolism, and endocrinology. However, the role of KLF16 in prostate cancer (PCa) remains unknown. METHODS: We screened the expression of KLFs in PCa based on bioinformatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Yu, Wandong, Wang, Xilong, Hu, Bo, Wu, Denglong, Shi, Guowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025737/ https://www.ncbi.nlm.nih.gov/pubmed/32103997 http://dx.doi.org/10.2147/OTT.S233495

Ejemplares similares

Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells
por: Wang, Qiang, et al.
Publicado: (2018)

USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
por: Ge, Jianchao, et al.
Publicado: (2021)

DDX52 knockdown inhibits the growth of prostate cancer cells by regulating c-Myc signaling
por: Yu, Wandong, et al.
Publicado: (2021)

KLF9 suppresses cell growth and induces apoptosis via the AR pathway in androgen-dependent prostate cancer cells
por: Shen, Pengliang, et al.
Publicado: (2021)

Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancer
por: Ma, Hangbin, et al.
Publicado: (2023)

Targeting eIF3f Suppresses the Growth of Prostate Cancer Cells by Inhibiting Akt Signaling
por: Li, Junhong, et al.
Publicado: (2020)

Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression
por: Hong, Zhe, et al.
Publicado: (2023)

The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors
por: Li, Jun-Chen, et al.
Publicado: (2021)

1470 nm Diode Laser Enucleation vs Plasmakinetic Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study
por: Zhang, Jun, et al.
Publicado: (2019)

N-Myc Regulates Expression of Pluripotency Genes in Neuroblastoma Including lif, klf2, klf4, and lin28b
por: Cotterman, Rebecca, et al.
Publicado: (2009)

Cardiac mesenchymal progenitors differentiate into adipocytes via Klf4 and c-Myc
por: Kami, D, et al.
Publicado: (2016)

KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone
por: Tassone, Evelyne, et al.
Publicado: (2019)

DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma
por: Jia, Xuebing, et al.
Publicado: (2022)

IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
por: Vecchio, Eleonora, et al.
Publicado: (2020)

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance
por: Sun, Nannan, et al.
Publicado: (2021)

A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors
por: Li, Zhen, et al.
Publicado: (2013)

Effects of Klf4 and c-Myc Knockdown on Pluripotency Maintenance in Porcine Induced Pluripotent Stem Cell
por: Liao, Yu-Jing, et al.
Publicado: (2018)

Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer
por: Huang, Qingqing, et al.
Publicado: (2023)

MYC DNA Methylation in Prostate Tumor Tissue is Associated with Gleason Score
por: Barry, Kathryn Hughes, et al.
Publicado: (2020)

Impact of carbohydrate restriction in the context of obesity on prostate tumor growth in the Hi-Myc transgenic mouse model
por: Allott, Emma H., et al.
Publicado: (2017)

Detailed Structural-Functional Analysis of the Krüppel-like Factor 16 (KLF16) Transcription Factor Reveals Novel Mechanisms for Silencing Sp/KLF Sites Involved in Metabolism and Endocrinology
por: Daftary, Gaurang S., et al.
Publicado: (2012)

Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer
por: Wang, Licheng, et al.
Publicado: (2021)

Transcription factor KLF16 activates MAGT1 to regulate the tumorigenesis and progression of breast cancer
por: Li, Lin, et al.
Publicado: (2022)

KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration
por: Chen, Xiaosong, et al.
Publicado: (2022)

KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
por: Wu, Yong, et al.
Publicado: (2023)

Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells
por: Barakat, David J., et al.
Publicado: (2018)

RNA-Seq Analysis Reveals a Negative Role of KLF16 in Adipogenesis
por: Jang, Min-Kyung, et al.
Publicado: (2016)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic
por: Aguirre, Marisol, et al.
Publicado: (2023)

Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer
por: Barfeld, Stefan J., et al.
Publicado: (2015)

KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6
por: Mi, Wei, et al.
Publicado: (2022)

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021)

CircRNA-UCK2 Increased TET1 Inhibits Proliferation and Invasion of Prostate Cancer Cells Via Sponge MiRNA-767-5p
por: Xiang, Zhendong, et al.
Publicado: (2019)

Simvastatin Improves Myocardial Ischemia Reperfusion Injury through KLF-Regulated Alleviation of Inflammation
por: Wei, Tingju, et al.
Publicado: (2022)

Down-regulation of the klf5-c-Myc interaction due to klf5 phosphorylation mediates resveratrol repressing the caveolin-1 transcription through the PI3K/PKD1/Akt pathway
por: Yang, Hui, et al.
Publicado: (2017)

Engineered zinc-finger transcription factors activate OCT4 (POU5F1), SOX2, KLF4, c-MYC (MYC) and miR302/367
por: Ji, Qingzhou, et al.
Publicado: (2014)

Tumor Growth Remains Refractory to Myc Ablation in Host Macrophages
por: Morrow, Riley J., et al.
Publicado: (2022)

MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer
por: Xiang, Jun, et al.
Publicado: (2015)

Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer
por: Hong, Liwei, et al.
Publicado: (2023)

Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth
por: Vilborg, A, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_uqt9a8t22bmvmsllgbgj878fgg